Immuron Limited (ASX:IMC)
Share Price and News

Company Profile:

Immuron Limited (ASX: IMC) is an Australian microbiome biopharmaceutical company which is involved in marketing and selling of Travelan® which is used for the prevention of Travelers’ Diarrhoea. The company is currently headed by Dr. Gary S. Jacob who is the CEO of the company. The headquarter of the company is located in Carlton, Victoria, Australia.

Code : ASX:IMC Healthcare Company